Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus or SLE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT02925351
What this trial is testing

Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases

Who this might be right for
Autoimmune DiseaseCrohn DiseaseInflammatory Disorder+3 more
Jonsson Comprehensive Cancer Center 8
Early research (Phase 1)Not Yet RecruitingNCT07512947
What this trial is testing

Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus

Who this might be right for
System Lupus Erythematosus(SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Early research (Phase 1)Not Yet RecruitingNCT07688980
What this trial is testing

Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 92
Early research (Phase 1)Looking for participantsNCT07109986
What this trial is testing

UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Nanjing IASO Biotechnology Co., Ltd. 21
Large-scale testing (Phase 3)Study completedNCT01551069
What this trial is testing

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Who this might be right for
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Sanofi 103
Early research (Phase 1)Active Not RecruitingNCT06294236
What this trial is testing

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Who this might be right for
Lupus ErythematosusSystemic Lupus ErythematosusSLE (Systemic Lupus)+3 more
Sana Biotechnology 7
Early research (Phase 1)Active Not RecruitingNCT05411016
What this trial is testing

KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus

Who this might be right for
Healthy VolunteersSystemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
Kyowa Kirin Co., Ltd. 157
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Testing effectiveness (Phase 2)Looking for participantsNCT07523542
What this trial is testing

SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUSLupus Nephritis
Beijing Biotech 24
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more
University of Sao Paulo General Hospital 2,005
Testing effectiveness (Phase 2)Ended earlyNCT05306873
What this trial is testing

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID) 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Early research (Phase 1)WithdrawnNCT06238531
What this trial is testing

A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Testing effectiveness (Phase 2)Study completedNCT03684564
What this trial is testing

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeSystemic Lupus ErythematosusStroke+2 more
University College, London 43
Not applicableNot Yet RecruitingNCT06999109
What this trial is testing

Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress

Who this might be right for
LupusDermatomyositis, JuvenileDermatomyositis+3 more
Duke University 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT07015983
What this trial is testing

CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89
Early research (Phase 1)Looking for participantsNCT07363590
What this trial is testing

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

Who this might be right for
Systemic Lupus ErythematosusRheumatoid Arthritis
Merck Sharp & Dohme LLC 21
Post-approval studies (Phase 4)Looking for participantsNCT07077486
What this trial is testing

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Who this might be right for
Lupus or SLEInterstitial Lung DiseaseSystemic Lupus Erythematosus
Tongji Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04451772
What this trial is testing

The Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Who this might be right for
Systemic Lupus Erythematosus (SLE)
AbbVie 185
Early research (Phase 1)Looking for participantsNCT07276958
What this trial is testing

LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Who this might be right for
HealthySystemic Lupus ErythematosusRheumatoid Arthritis
Eli Lilly and Company 68
Next Page